Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1998
11/03/1998US5830640 Analyzing for uteroglobin protein in cells
11/03/1998US5830637 Solid phase support, separate zone functions
11/03/1998US5830634 Aids diagnosis, screening blood doners
11/03/1998US5830504 Cooperative combinations of ligands contained within a matrix
11/03/1998US5830477 Vaccine against rabies and process for preparation thereof
11/03/1998US5830476 Active induction or passive immunization of anti-Gp48 antibodies and isolated gp48 protein
11/03/1998US5830475 Recombinant mycobacterial vaccines
11/03/1998US5830472 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
11/03/1998US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998US5830467 Pharmaceutical preparation containing protein C and a thrombolytically active substance
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830462 Regulated transcription of targeted genes and other biological events
11/03/1998US5830458 Method for destroying a diseased human cell
11/03/1998US5830457 Recombinant beta-lactamase, usable as carrier molecule in immunogenic compositions
11/03/1998US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
11/03/1998US5830451 Diagnosis of pregnancy, modulation of immune system to prevent spontaneous abortion, reduce graft verses host
11/03/1998US5830450 Compositions of leptin bound to an apolipoprotein
11/03/1998US5830431 Radiolabeled peptide compositions for site-specific targeting
11/03/1998US5830430 Cationic lipids and the use thereof
11/03/1998CA2087532C Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal
11/03/1998CA2058443C Treating disorders by application of insulin-like growth factors and analogs
11/03/1998CA1340112C Supression of cell proliferation by decorin
11/03/1998CA1340111C Vectors and compounds for expression of zymogen forms of human protein c
11/03/1998CA1340110C Carcinoma-associated antigens, and antibodies which recognize these antigens
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048283A1 Recombinant rabbit tissue factor based prothrombin time reagent
10/29/1998WO1998048264A1 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
10/29/1998WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998WO1998048051A2 Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof
10/29/1998WO1998048032A2 POLY-(α-L-ASPARTIC ACID), POLY-(α-L-GLUTAMIC ACID) AND COPOLYMERS OF L-ASP AND L-GLU, METHOD FOR THEIR PRODUCTION AND THEIR USE
10/29/1998WO1998048026A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998WO1998048025A2 Regulatory system for inducible expression of genes with lambdoid promoters
10/29/1998WO1998048024A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998WO1998048022A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
10/29/1998WO1998048021A1 Kaposi's sarcoma herpesvirus (hhv8) protease and assembly protein
10/29/1998WO1998048020A2 Mammalian ubiquitin-isopeptidases that control cell proliferation
10/29/1998WO1998048018A1 Recombinant human beta interferon with enhanced solubility
10/29/1998WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998048015A1 Transcriptional regulator
10/29/1998WO1998048014A1 Cancer marker
10/29/1998WO1998048013A1 Brca2 transcriptional activator domain and uses thereof
10/29/1998WO1998048011A1 Novel chimeric molecules
10/29/1998WO1998048010A1 Novel human tumour suppressor gene
10/29/1998WO1998048007A1 Phytochrome regulated transcription factor for control of higher plant development
10/29/1998WO1998048004A1 Method and compositions for stabilizing unstable gene transcripts
10/29/1998WO1998047923A1 Il-5r antagonists for treatment of inflammation, asthma and other allergic diseases
10/29/1998WO1998047921A1 Mammalian cytokines; related reagents and methods
10/29/1998WO1998047920A1 Transcriptional regulator
10/29/1998WO1998047919A1 Materials and methods relating to stabilising substances in cells
10/29/1998WO1998047918A1 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/29/1998WO1998047917A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
10/29/1998WO1998047916A1 Bifunctional polypeptides for cell-specific viral targeting
10/29/1998WO1998047915A1 Neoglycoproteins
10/29/1998WO1998047914A2 Us6 gene from the human cytomegalovirus (hcmv)
10/29/1998WO1998047913A2 Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
10/29/1998WO1998047528A1 Method of treating hypertension using a composition containing a dried animal stomach mucosa and endogenous protease-inhibitor peptides
10/29/1998WO1998047524A1 Gastrin receptor-avid peptide conjugates
10/29/1998WO1998047522A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998WO1998047489A1 Sustained-release compositions and method for preparing same
10/29/1998WO1998047361A1 Treatment for diabetes
10/29/1998WO1998047343A2 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998WO1998035045A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/29/1998WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998WO1998028971A3 Transgenic animals for in vivo visualization of beta-amyloid toxicity
10/29/1998WO1998028332A3 Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2; compositions and uses thereof
10/29/1998WO1998027205A3 Secreted proteins and polynucleotides encoding them
10/29/1998WO1998023762A3 Methods of producing a recombinant protein
10/29/1998WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998WO1998021233A3 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/29/1998WO1998017805A3 Invasion associated genes from neisseria meningitidis serogroup b
10/29/1998DE19717864A1 Humanes rekombinantes Interferon-beta mit verbesserter Löslichkeit Human recombinant interferon-beta with improved solubility
10/29/1998CA2288976A1 Phytochrome regulated transcription factor for control of higher plant development
10/29/1998CA2288335A1 Brca2 transcriptional activator domain and uses thereof
10/29/1998CA2288227A1 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
10/29/1998CA2288058A1 Recombinant rabbit tissue factor based prothrombin time reagent
10/29/1998CA2288027A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998CA2287590A1 Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof
10/29/1998CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998CA2287438A1 Novel human tumour suppressor gene
10/29/1998CA2287254A1 Mammalian cytokines; related reagents and methods
10/29/1998CA2286933A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998CA2286865A1 Edg-1-like receptor
10/29/1998CA2286612A1 Treatment for diabetes
10/29/1998CA2286210A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998CA2284729A1 Neoglycoproteins
10/29/1998CA2283854A1 Gastrin receptor-avid peptide conjugates
10/29/1998CA2283755A1 Human complement c3-degrading proteinase from streptococcus pneumoniae
10/29/1998CA2259243A1 Method of treating hypertension using a composition containing a dried animal stomach mucosa and endogenous protease-inhibitor peptides
10/28/1998EP0874057A2 Vector and mammalian cell line having improved productivity
10/28/1998EP0874055A2 Method for the protection of plants against pathogens
1 ... 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 ... 2916